Daniel Brice

Daniel Brice is a Researcher in the Division of Immunology, Immunity to Infection and Respiratory Medicine. His work focuses on immunological mechanisms in oncology and gastrointestinal diseases, contributing to UN Sustainable Development Goals related to health and well-being.

Research interests include protein expression profiling in cancer progression, cytokine regulation in epithelial barriers, biomarker discovery for gastrointestinal neoplasms, and therapeutic strategies for inflammatory bowel disease. His interdisciplinary approach combines organoid models, histopathological analysis, and molecular biology techniques.

Key contributions include identifying HMGB1 as a prognostic marker in colorectal cancer, elucidating IL-27's role in gastrointestinal immunity, and proposing novel therapeutic pathways for inflammatory conditions. Collaborations span immunology, oncology, and clinical research disciplines.